Published in JAMA on June 13, 2001
Interaction revisited: the difference between two estimates. BMJ (2003) 11.97
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ (2003) 1.63
Making decisions about hormone replacement therapy. BMJ (2003) 1.38
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ (2004) 1.18
Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int (2005) 1.18
High-intensity resistance training and postmenopausal bone loss: a meta-analysis. Osteoporos Int (2006) 1.17
Individualizing osteoporosis therapy. Osteoporos Int (2012) 1.15
Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol (2013) 1.10
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol (2011) 1.04
Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? JAMA (2001) 1.04
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int (2004) 1.01
The treatment of climacteric symptoms. Dtsch Arztebl Int (2012) 0.98
Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J (2006) 0.93
Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet Disord (2001) 0.93
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int (2009) 0.92
The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study. Osteoporos Int (2011) 0.89
Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature. Osteoporos Int (2005) 0.86
Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab (2008) 0.86
Estrogen regulation of apoptosis in osteoblasts. Physiol Behav (2009) 0.86
Change in the use of hormone replacement therapy and the incidence of fracture in Oslo. Osteoporos Int (2008) 0.84
Fracture prevention in postmenopausal women. BMJ Clin Evid (2011) 0.84
Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures. Osteoporos Int (2003) 0.83
Management of age-related osteoporosis and prevention of associated fractures. Ther Clin Risk Manag (2006) 0.83
Risk factors for fracture of the shafts of the tibia and fibula in older individuals. Osteoporos Int (2005) 0.83
Osteoporosis. Postgrad Med J (2002) 0.82
The effects of tualang honey on bone metabolism of postmenopausal women. Evid Based Complement Alternat Med (2012) 0.81
Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Br J Clin Pharmacol (2007) 0.80
Nutrition and bone health projects funded by the UK Food Standards Agency: have they helped to inform public health policy? Br J Nutr (2008) 0.80
The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. J Osteoporos (2011) 0.80
Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny (2014) 0.79
Effect of combined sex hormone replacement on bone/cartilage turnover in a murine model of osteoarthritis. Clin Orthop Surg (2012) 0.79
Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study. Eur J Epidemiol (2004) 0.78
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Dig Dis Sci (2006) 0.78
The effects of soy isoflavone on bone density in north region of climacteric Chinese women. J Clin Biochem Nutr (2013) 0.77
The response to sex steroid hormones and vitamin D of cultured osteoblasts derived from ovariectomized mice with and without 17beta-estradiol pretreatment. Odontology (2005) 0.77
Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review. Int J Womens Health (2010) 0.77
Hormone therapy and risk of non-vertebral fracture: Geelong osteoporosis study. Osteoporos Int (2004) 0.76
The Estrogen Receptor α-Cistrome Beyond Breast Cancer. Mol Endocrinol (2016) 0.76
Surgical prevention of femoral neck fractures in elderly osteoporotic patients. A literature review. Clin Cases Miner Bone Metab (2016) 0.76
The tissue selective estrogen complex: a promising new menopausal therapy. Pharmaceuticals (Basel) (2012) 0.76
Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment. PLoS One (2011) 0.75
Antiresorptive agents increase the effects of exercise on preventing postmenopausal bone loss in women: a meta-analysis. PLoS One (2015) 0.75
Psoralen Inhibited Apoptosis of Osteoporotic Osteoblasts by Modulating IRE1-ASK1-JNK Pathway. Biomed Res Int (2017) 0.75
Effects of ultrasound on estradiol level, bone mineral density, bone biomechanics and matrix metalloproteinase-13 expression in ovariectomized rabbits. Exp Ther Med (2015) 0.75
Hormone replacement therapy after the menopause--where are we now? Br J Gen Pract (2005) 0.75
Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists. ACS Med Chem Lett (2016) 0.75
Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials. BMJ Open (2016) 0.75
Estrogen receptor α (ESR1) IVS1-397T>C polymorphism lowers risk of fracture. Int J Clin Exp Med (2015) 0.75
Estrogen treatment does not reduce fractures? Menopause (2014) 0.75
A meta-analysis of hormone replacement therapy for fracture prevention. JAMA (2001) 0.75
Long-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized rats. Biomed Rep (2017) 0.75
Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ (1999) 1.70
Extracts from "Clinical evidence": Athlete's foot and fungally infected toenails. BMJ (2001) 1.41
Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev (2000) 1.12
Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC Musculoskelet Disord (2001) 0.93
Fungal infections of skin and nails of feet. Authors of meta-analysis defend their view. BMJ (1999) 0.75